Optical coherence tomography (OCT) has become the invasive imaging modality of choice for coronary stent assessment due to its unmatched spatial resolution. Neointimal calcification (NC) is a rare finding, observed in 5-10% of in-stent restenosis (ISR) neointima. The impact of NC on percutaneous coronary intervention of ISR is unknown. We therefore present the outcome of six unique cases of ISR and NC in which OCT was used to evaluate the impact of NC on the quality of stent-in-stent deployment for the treatment of ISR. This series demonstrates for the first time the impact of NC on stent expansion, a finding which might help guiding percutaneous coronary intervention for ISR with NC.
Brief Communication
Neoatherosclerosis, defined as the presence of neointimal calcification (NC) or lipid-laden neointima, 1 has been reported as an important mechanism of late stent failure. 2 Intravascular imaging modalities enabled further elucidation of neoatherosclerosis´ pathophysiology in vivo. 3 Neointimal calcification is observed in 5-10% of in-stent restenosis (ISR), 4 but its impact on the acute performance of stents implanted in-stent for the treatment of ISR is unknown. Intravascular optical coherence tomography (OCT) enables precise assessment of calcified plaques, while dramatically reducing imaging artifacts compared with intravascular ultrasound. 5 We therefore used OCT to evaluate the impact of NC on the quality of stent-in-stent deployment for the treatment of ISR.
Herewith we present 6 cases of ISR and NC from our institution's OCT registry. OCT (C7-XR OCT Intravascular Imaging System; St.Jude Medical, St. Paul, Minnesota) images were acquired pre-and post-stent-in-stent procedure using the integrated automated pullback device at 20 mm/s (frame interval of 0.2 mm). Neointimal calcification was defined as an area of low attenuation, low backscattering and clear borders within the stent neointima (Figure 1 ). Areas and diameters for the old (outer) and newly implanted (inner) stents were obtained; in addition, the mean distance and area between the stents were automatically obtained by 360° chords (Figure 1 ). Stent eccentricity was defined as minimum stent diameter/ maximum stent diameter, while stent expansion was defined as the average stent area at the NC zone divided by the average stent reference [(average proximal reference + average distal reference)/2]. OCT analysis was undertaken offline by a Core Laboratory blinded to the procedure´s characteristics using commercially available software (Version C.0.4, St Jude Medical, St. Paul, MN). Analyses were concentrated in 3 consecutive frames at 3 different locations (i.e. 9 frames per OCT pullback): 1) NC region, 2) proximal and 3) distal to NC region (Figure 1 ). Stent areas, diameters and stent eccentricity were similar between the frames with NC and the frames distal to the NC (Table 1) . When comparing the NC area to the ISR region proximal to the NC, there was a trend for smaller area (difference = 0.9 mm 2 , p = 0.09), and diameter (difference = 0.2mm, p = 0.09) of the inner (newly implanted) stent and bigger stent area (difference = 1.2 mm 2 , p = 0.06), and diameter (difference = 0.2mm, p = 0.06) of the external (older) stent at the location of NC compared to the proximal non-calcified ISR analyzed frames ( Table 1 ).
The mean distance between the stents was always longer at the area of calcification: difference between the NC area and the distal area was 0.13mm (p = 0.02) and the NC area and the proximal ISR region as 0.21 (p = 0.01). The average stent expansion at the area of calcified neointima was 81.4%. Stent underexpansion has been linked to clinical adverse events, notably stent thrombosis and restenosis. 6, 7 We were able to demonstrate that the presence of NC led to underexpansion of the newly implanted stent compared with adjacent segments. Further investigation is required to determine whether these findings have an impact on clinical events.
The mechanisms leading to stent ISR have been divided into technical (barotrauma outside stented segment, stent gap, residual uncovered atherosclerotic plaques), mechanical (stent underexpansion, non-uniform stent strut distribution, stent fracture, non-uniform drug elution/ deposition, polymer peeling) and biological (drug resistance, hypersensitivity). 8 The advancement of intravascular imaging, notably OCT, is expected to allow a better understanding of the ISR process and will likely influence the therapeutic strategies (i.e., customized therapy) utilized in this scenario. While current alternatives for ISR therapy (i.e., plain balloon angioplasty,
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